Monoclonal Antibody Therapy

Berkshire Health Systems has been leading the way in Massachusetts in the use of Monoclonal Antibody Therapy to help COVID-19 patients who are mildly symptomatic and are at risk for progressing to a more severe form of the illness that could require hospitalization. For information on what Monoclonal Antibodies are and eligibility, please visit this website of the Federal Department of Health & Human Services. 

If you are a provider interested in enrolling a patient or patients for Monoclonal Antibody Therapy at BHS, please use the link below to place an order:

• Provider Request Form for COVID Monoclonal Antibodies